Enterprise Value
12.22B
Cash
199.1M
Avg Qtr Burn
-9.505M
Short % of Float
14.48%
Insider Ownership
3.91%
Institutional Own.
91.31%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|